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Lipid rafts are highly dynamic membrane domains featured by distinctive biochemical 2 
composition and physicochemical properties compared to the surrounding plasma membrane. 3 
These microstructures are associated not only with cellular signalling and communication in 4 
normal nerve cells but also with pathological processing of amyloid precursor protein in 5 
Alzheimer’s disease. Using lipid rafts isolated from human frontal cortex in non-demented 6 
subjects aging 24-85 years, we demonstrate here that lipid structure of lipid rafts undergo 7 
significant alterations of specific lipid classes and phospholipid-bound fatty acids as brain cortex 8 
correlating with aging. Main changes affect levels of plasmalogens, polyunsaturated fatty acids 9 
(especially docosahexaenoic acid and arachidonic acid), total polar lipids (mainly 10 
phosphatidylinositol, sphingomyelin, sulphatides and cerebrosides), and total neutral lipids 11 
(particularly cholesterol and sterol esters). Besides, relevant relationships between main fatty 12 
acids and/or lipid classes were altered in an age-related manner. This “lipid raft aging” exhibits 13 
clear gender differences and appear to be more pronounced in women than in men, especially 14 
in older (postmenopausal) women. The outcomes led us to conclude that human cortical lipid 15 
rafts are modified by aging in a gender-dependent fashion. Given the central role of bilayer lipid 16 
matrix in lipid rafts functionality and neuronal signalling, we hypothesize that these findings 17 
might underlie the higher prevalence of cognitive decline evolving towards Alzheimer´s disease 18 
in postmenopausal women.  19 
Keywords:  Aging, gender differences, lipid rafts, membrane lipids, plasmalogens, sphingolipids, 20 
long-chain polyunsaturated fatty acids, cholesterol. 21 
















Cerebral aging is generally acknowledged as a complex process involving multiple factors which 2 
converge to reduce cognitive functions, eventually leading to neuronal vulnerability and the 3 
development of pathological conditions that favour neurodegenerative diseases. Amongst 4 
these factors, nutritional habits, genotype, and hormonal status are increasingly recognized in 5 
the likelihood of developing neurodegenerative pathologies. For instance, cholesterol-rich and 6 
high saturated fat (prevalent in the Western diet), are regarded as risk factors for brain aging 7 
and dementia (Collin et al 2016; Davidson et al., 2013; Park et al., 2013; Uranga et al., 2010), as 8 
well as to higher incidence of Alzheimer's disease (AD) (Julien et al., 2010; Refolo et al., 2000). 9 
Indeed, compelling evidence accumulated over the last two decades have led to the notion that 10 
lipid alterations in the brain parenchyma affect the organization of the neuronal membrane, 11 
particularly in the structure and functionality of specific microdomains, such as lipid rafts 12 
(recently reviewed in Collin et al., 2016). As lipid composition impact phase separation of 13 
membrane domains, it appears evident that age-associated variations in lipid composition 14 
would lead to modifications of the physicochemical properties of membranes. This fact 15 
provides a mechanistic link for age-related disturbances of lipid raft functionality, particularly in 16 
synaptic membranes, neurotransmission, neurotransmitter signalling and transduction, protein 17 
clustering, potentially contributing to neuropathological events (Sebastião et al., 2013). For 18 
instance, aged mice hippocampi have decreased density of TrkB, glutamatergic AMPA and 19 
NMDA receptors in lipid rafts, as well as decreased density of caveolin-1, a cholesterol binding 20 
protein relevant for lipid raft organization (Head et al., 2010: Martín et al., 2010a). These lead 21 
to reallocation of glutamatergic receptors to non-raft domains which favour excitotoxic events 22 
(Collin et al., 2016; Liu et al., 2007). The importance of perturbing lipid rafts or membrane lipid 23 
composition in the functionality and modulation of several ionotropic and metabotropic 24 
receptors, GABAergic, cholinergic, serotonergic, purinergic, dopaminergic and neurotrophic 25 
factor receptors has been well established (reviewed in Sebastião et al., 2013). Importantly, we 26 
have recently found that changes in the lipid composition and biophysical properties of 27 
neuronal membrane domains in human brains, particularly the reduction of cholesterol and 28 
polyunsaturated fatty acids (PUFA) in lipid rafts, facilitates the clustering and interaction of 29 
proteins involved in the amyloidogenic cascade, thereby formation and aggregation of Amyloid 30 















In close connection with brain lipid metabolism, it has been solidly established that the 1 
presence of the apolipoprotein E4 alelle is a primary genetic risk for sporadic AD. The evidence 2 
is clear: although only 20% of humans carry this allele (ApoE4), about 60% of them progress to 3 
AD (reviewed in Mayeux, 2003). However, is spite of intense research, the mechanistic 4 
connection between this genetic feature and AD pathogenesis is not clear. A recent study by 5 
Zhu et al. (2015) have revealed that the ApoE4 isoform is a critically determinant of 6 
phospholipid homeostasis, and that its presence reduces levels of phosphatidylinositol (which 7 
are particularly abundant in the inner leaflet of lipid rafts) secondary to increased expression of 8 
PIP2-degrading enzyme, thereby affecting lipid signalling (Zhu et al., 2015). In addition, other 9 
(epi)genetic mechanisms appear to be involved. Such is the case of age-related changes in DNA 10 
methylation in neuronal and glial genomes, which have been reported to be responsible for 11 
aging-induced changes in gene expression, including genes involved in brain lipid metabolism 12 
(Steegenga et al., 2014). However, a cause-effect relationship has yet to be demonstrated.  13 
Cumulative epidemiological and basic research evidences have involved age-related changes in 14 
hormonal status in brain lipid changes. Amongst best studied hormonal influences, the decline 15 
of estrogens during menopause has received great attention. Indeed, postmenopausal 16 
reduction of circulating estrogens affect lipid metabolism both at the systemic (mainly liver) 17 
and brain parenchyma levels. In our recent study, using wild type and transgenic APP/PS1 mice 18 
(a model of familial AD), we demonstrated that estrogen deprivation leads to significant 19 
changes in hippocampal lipid composition and lipid-related gene expression, including Acat 20 
family of genes (responsible for generation of steryl/cholesteryl esters), HMGCoAR (involved in 21 
de novo synthesis of cholesterol), and Scd1 and Scd2 (encoding for Δ9-desaturases) (Díaz et al. 22 
2015b). Noteworthy, the effects of estrogen deprivation/restoration were tightly linked to diet, 23 
and particularly to the amount of DHA included therein. Paralleling these findings, it has been 24 
recently demonstrated that estrogen deprivation in humans, i.e postmenopausal women, leads 25 
to the disruption of estrogen receptors(ER)-containing signalosomes 26 
(mER/IGF1Rβ/VDAC1/Caveolin-1) located in lipid rafts (Canerina-Amaro et al., 2017).  The 27 
alterations of this protein multicomplex may be a consequence of lipid raft lipid membrane 28 
disarrangements.  Indeed, the relevance of this signalosome disruption is enormous since it has 29 
been demonstrated to participate in the neuroprotective actions of estrogens and IGF1 (García-30 















In the present study we have aimed to endeavour a complete analysis of lipid raft lipid 1 
composition in human frontal cortex from non-demented (healthy) subjects, with particular 2 
emphasis in the effects of aging and gender. We have also analysed potential interactions 3 
between these factors. To the best of our knowledge, this represents the first overall study on 4 
the influence of aging and gender in the lipid composition of human cortex membrane 5 
microdomains.  6 















Materials and Methods. 1 
Human Brain tissue and isolation of lipid rafts. Brain tissues were obtained from the Institute of 2 
Neuropathology Brain Bank from Hospital Universitario de Bellvitge (Barcelona, Spain) following 3 
the guidelines of the ethics committee. Twenty five cases of Caucasian individuals 4 
neurologically normal and without neuropathological traits at autopsy were analysed. Groups 5 
were established according to their age and gender as young men (Men < 60, average age 6 
42.86 ± 1.93, ranging 38-52 years), young  women (Women < 60, average age 42.20 ± 4.11, 7 
ranging 24-49 years), aged men (Men > 60, average age 73.29 ± 3.0, ranging 64-85 years), and 8 
aged women (Women > 60, average age 71.67 ± 2.38, ranging 65-82 years). A summary of cases 9 
including post-mortem delays, primary disease and cause of death is shown in Table 1.  Frontal 10 
cortex grey matter was used for the isolation of tissue homogenates and lipid rafts. Cases were 11 
processed following standard sampling, staining and immunohistochemistry protocols as 12 
described previously (Fabelo et al., 2014; Martín et al., 2010a). At autopsy, half of the brain was 13 
fixed in formalin and the other half was cut in coronal sections of selected brain regions and 14 
immediately frozen and stored at -80ºC until membrane isolation. Cortical homogenates and 15 
Lipid raft fractions were isolated following the protocols previously described for human brain 16 
in sucrose gradients centrifuged at 150,000xg for 18 h at 4ºC (Fabelo et al., 2011; 2014; Martín 17 
et al., 2010a). Two ml fractions were collected from the top to the bottom from the 18 
ultracentrifuge tubes, re-suspended in 200 µl of homogenization buffer and frozen at -80 ºC 19 
until analysis. 20 
Lipid analyses. Total lipids from lipid rafts fractions were extracted with chloroform/methanol 21 
(2:1 v/v) containing butylated hydroxytoluene (BHT, 0.01%) as antioxidant. Lipid classes were 22 
separated by one-dimensional double development high performance thin layer 23 
chromatography using methyl acetate/isopropanol/chloroform/methanol /0.25% KCl 24 
(5:5:5:2:1.8 volume basis) as developing solvent system for polar lipid classes, and 25 
hexane/diethyl ether/acetic acid (22.5:2.5:0.25 volume basis) as developing solvent system for 26 
neutral lipids. Lipid classes were quantified by scanning densitometry after charring plates with 27 
3% (w/v) aqueous cupric acetate containing 8% (v/v) phosphoric acid, using a Shimadzu CS-28 
9001PC dual wavelength spot scanner. Lipids from lipid rafts were subjected to acid-catalyzed 29 
trans-methylation using 1 mL of toluene and 2 ml of 1% sulfuric acid (v/v) in methanol for 16h 30 















in thin layer chromatography (TLC), and quantified using a TRACE GC Ultra (Thermo Fisher 1 
Scientific, Waltham, MA, USA) gas chromatograph equipped with a flame ionization detector. 2 
Individual FAME and DMA were identified by reference to a multi-standard mixture (Supelco 3 
PARK, Supelko, Bellefonte, USA), and confirmed using a DSQ II mass spectrometer (Thermo 4 
Fisher Scientific, Waltham, MA, USA). 5 
Statistical methods. Lipid variables were initially assessed by one-way analyses of variance 6 
(ANOVA-I) followed by Tukey’s or Games-Howell post hoc tests, where appropriate. Kruskal-7 
Wallis and Mann-Whitney U tests were used in cases where normality was not achieved. Data 8 
were afterwards analysed by two-way or multiple analyses of variance (ANOVA-II) in order to 9 
determine main effects between the different factors, and to assess the existence and degree 10 
of interactions. Lipid classes and main fatty acids were additionally submitted to multivariate 11 
analyses using principal components analysis (PCA), in order to obtain the extraction coefficient 12 
matrixes of lipid components and their contributions to overall variance and weights in group 13 
segregation. Factor scores from principal component 1 (PC1) were used to obtain the lipid 14 
profile of each experimental group. Factor scores were further analysed by two-way ANOVA to 15 
evaluate the main effects of diet, hormonal status and genotype, as well as their interactions, in 16 
the lipid signatures of the different groups. Pearson and partial correlation analyses as well as 17 
lineal regression analyses were performed in order to assess the significance of bivariate 18 
relationships between different lipids, and to explore for the effects of age and gender factors 19 
in setting their relationships.  20 
















Lipid profiles in lipid rafts isolated from women and men as a function of aging. We first 2 
analysed the lipid classes and fatty acid composition of lipid rafts from women and men aging 3 
24-85 years. Results in Table 2 revealed significant differences extending to both lipid classes 4 
and fatty acids. Within younger individuals, most lipid variables remained similar regardless 5 
gender, although women displayed lower (or null) levels of dimethylacetals 16:0 DMA, 18:1n-9 6 
DMA, 18:1n-7 DMA, total n-3 LCPUFA, unsaturation index (UIx) and, peroxydability index (PIx). 7 
Significant lower levels of 20:4n-6 and 22:5n-6, and higher levels of 22:0, 22:2n-6 and 8 
sulphatides were observed in aged individuals in both sexes. Cholesterol was reduced by 9 
average 8.9% in older individuals, though this reduction was not statistically significant 10 
(p=0.072). Older men (but not women) displayed lower levels of 18:1n-9 DMA, 18:1n-7 DMA, 11 
UIx, PIx indexes as well as higher levels of 22:0, 23:0, 18:1n-7 and 24:1n-9. Conversely, 12 
compared to aged men, aged women exhibited higher contents of 18:1n-9 (partly reflected in 13 
total monoenoic fatty acids), sulphatides and cerebrosides, and lower amounts of 18:1n-9 14 
DMA, 18:1n-7 DMA (but not total DMA). 15 
Given that group ages span a wide range (24-85 years), and that a number of differences were 16 
close to achieve statistical significance, we next performed correlation analyses between all 17 
lipid variables and age. We used both Pearson correlation analyses on pooled samples (women 18 
and men), as well as partial correlations to detect changes controlled by age. The results 19 
illustrated in Figure 1 and Table 3, revealed that while some regression lines followed the same 20 
trends in both sexes, other relationships were markedly different.  Thus, total n-3 LCPUFA fatty 21 
acids (r=0.707), n-3/n-6 ratio (r=0.714), UIx (r=0.611), PIx (r=0.562), 20:0 (r=0.638), 22 
phosphatidylethanolamine (PE, r=0.533) increased with age in women but not in men (Fig. 1A 23 
and Table 3). Likewise, levels of 16:0 DMA, 18:1n-9 DMA and 18:1n-7 DMA were undetectable 24 
in women, instead all plasmalogens in women appear to contain only the more saturated 18:0 25 
DMA. Lipid rafts from men exhibited significant relationships for 18:1n-7 (r=0.559), 24:1n-9 26 
(r=0.687) and sphingomyelin (r=0.476) with age, which were not observed in women (Fig. 1B 27 
and Table 3). Correlations of pooled data showed that 18:2n-6 (r=-0.363), 20:3n-6 (r=-0.385), 28 
22:2n-6 (r=0.403), 22:5n-3 (r=0.370), total n-6 (r=-0.343), cholesterol (r=-0.357), sulphatides 29 
(r=0.309), TNL (r=-0.416) and TPL (r=0.416), exhibited identical significant trends in both sexes 30 















assumption was confirmed by using partial correlation analyses controlling for gender (Table 3), 1 
which revealed that all these relationships remained with little or no modifications.  2 
Lipid profiles in frontal cortex. In order to evaluate whether changes in lipid rafts resemble 3 
alterations in the cortical parenchyma, we analysed the lipid profiles in frontal cortex grey 4 
matter. The results are summarized in Table 4. We observed that only small changes, mostly 5 
affecting minor fatty acids were detected between groups. Nonetheless, it is worth mentioning 6 
that some clear age-related trends were observed for the reduction in the levels of cholesterol 7 
and total n-6 LCPUFA in women, but not in men, while 20:4n-6 and DHA levels exhibited a trend 8 
to decrease, and saturates to increase in both sexes. As expected, levels of TG and DAG were 9 
undetectable, as were those of LPC, indicating the absence of lipid peroxidation in frontal 10 
cortex samples 11 
Multivariate analyses of lipid rafts lipid profiles. Effects of gender, aging and interactions. We 12 
next attempted to determine the set of overall variables that might differentiate between age-13 
gender groups. We used a variable reduction strategy based on principal component analyses 14 
(PCA). Given the requirements of PCA analyses of lipid classes and fatty acids were analysed 15 
separately and the results are illustrated in Figures 2 and 3.  16 
We found that three principal components were able to explain most overall variance (73.85% 17 
for lipid classes and 65.51% for fatty acids). In the rotated component matrix, PC1 (34.51% of 18 
total variance) was positively related to PS and PI (more abundant in women) and negatively to 19 
sulphatides (more abundant in men) (see Table 2). PC2 (20.41% of total variance) was positively 20 
associated to PE and SE in both cases, and negatively to SM (all exhibiting opposite trends in 21 
women and men) and cholesterol (more abundant in younger subjects); while PC3 (12.39% of 22 
total variance) was positively correlated to PC (less represented in younger men) and negatively 23 
to cholesterol (more abundant in younger subjects) and free fatty acids (more abundant in 24 
older subjects). Plots of factor scores 1 and 2 revealed that age and gender factors are 25 
distributed in different regions of the 2D plots (Fig. 2 A and B), though a significant overlapping 26 
exists. Factor score plots for the whole dataset in the 3D space are illustrated in Fig. 2C. It can 27 
be observed a certain degree of segregation between groups, with groups Women > 60 and 28 
Men < 60 the ones most clearly differentiated. In order to detect main factors and interactions 29 















three factor scores. It turned out that age (F=8.43, p=0.008) and gender (F=3.33, p=0.082) were 1 
the main factors in determining factor score 1 (Fig. 2D). No interaction was detected between 2 
age and gender for this factor score. As gender only reached poor statistical significance, this 3 
indicates that most variance (attributed to PC1) is explained by age management.  Conversely, 4 
for factor score 2, age (F=5.71, p=0.026) and gender (F=4.69, p=0.042) were significant as main 5 
determinant factors, but interestingly, a strong interaction was detected between them 6 
(F=6.32, p=0.020) (Fig. 2E). No significant effects were observed in factor score 3 (not shown) 7 
When applied to fatty acids, PCA revealed again that three principal components explained a 8 
large proportion of variance (65.51%), with PC1, PC2 and PC3 accounting for 33.89%, 20.59 and 9 
PC3 11.36%, respectively. The component matrix indicated that PC1 was positively related to 10 
16:0 DMA, 17:0, 18:1n-9 DMA, 18:1n-7 DMA, 20:4n-6 and 22:6n-3 (more abundant in women), 11 
and negatively to 23:0, 22:2n-6, 20:2n-6 and 16:2 (more abundant in men). PC2 was related to 12 
saturates 14:0, 15:0, 22:0 and monoenoic 16:1 (generally more abundant in older subjects) and 13 
negatively to polyunsaturated 20:2n-6, 20:3n-6 and saturate 18:0 (more abundant in women). 14 
Finally, PC3 was positively related to main saturates 16:0, 18:0 and to 22:5n-3 (more abundant 15 
in women), but negatively to 18:1n-9 and 20:1 (more abundant in men). Plotting factor scores 1 16 
and 2 for age and gender conditions showed a complex scatterplot, especially for women and 17 
younger subjects (Fig. 3A and B). However, in the 3D space, plotting of factor scores for the 18 
whole dataset revealed a clear distribution of individual groups with a neat segregation 19 
between Women > 60 and Men < 60 (Fig. 3C), as it was observed in the case of lipid classes 20 
described above. Analyses of main factors and interaction using two-way ANOVA, indicated 21 
that for factor score 1 the main significant determinant was the interaction between age and 22 
gender (F=3.037, p=0.096) (Fig. 3D). Conversely, for factor score 2, both gender (F=7.376, 23 
p=0.013) and age (F=12.12, p=0.002) as main factors, as well as their interaction (F=9.735, 24 
p=0.005) were highly significant. 25 
Regression analyses of lipid profiles in in lipid rafts from women and men as a function of 26 
gender. We next performed regression analyses between relevant fatty acids and lipid classes 27 
in both sexes. The results shown in Fig. 4 and Supplementary Table 1 indicate that a number of 28 
relevant relationships between lipid classes and/or fatty acids and indexes are present which 29 
are statistically significant. For instance, DHA (22:6n-3) is positively correlated to PI and PS (Fig. 30 















related to PI in both sexes, but not to PS (Fig. 4C and Supplementary Table 1). Likewise, 1 
plasmalogens (as estimated from dimethylacetals) are positively related to 20:4n-6 and 22:6n-3 2 
in men but not in women (Fig. 4E and 4F). In this same lipid class, it turns out that saturated 3 
16:0 DMA and monounsaturated 18:1n-7 DMA and 18:1n-9 DMA, were totally excluded form 4 
women’s lipid rafts, where the only dimethylacetal species detected was 18:0 DMA (Table 2). 5 
Further, in men, DHA levels displayed a negative relationship with 18:1n-9, which was not 6 
observed in women. Likewise, sulphatides and cerebrosides exhibited a very significant positive 7 
covariation in men that was absent in women (Fig. 4I). Despite these bivariate differences, a 8 
number of relationships are shared by both sexes. Some of them are physiologically relevant. 9 
Such is the case of the negative relationship between 18:1n-9 and 18:0 (Fig. 4D), the negative 10 
association between LCPUFA and 18:1n-9 (Fig 4G), and the positive and negative relationships 11 
between PC and saturates and unsaturates, respectively (Fig. 4K and 4L). Of particular interest 12 
is the association between SM and long chain saturates 23:0 and 24:0 (Supplementary Table 1), 13 
which has structural impact in transbilayer stability. 14 
















In the present study, we demonstrate for the first time that non-pathological aging is 2 
accompanied by alterations in the lipid matrix of lipid rafts in the human frontal cortex.  These 3 
alterations affect both lipid classes and fatty acids. These changes appear to develop gradually 4 
as demonstrated when lipid data were plotted against subject age (Figure 1 and Table 3). Thus, 5 
there appear to occur a progressive decline in the levels of total n-6 LCPUFA, 18:2n-6, 20:3n-6, 6 
22:5n-6, TNL and cholesterol as well as a gradual increase in the levels of 22:5n-3, 22:2n-6, 7 
sulphatides and TPL.  Altogether, these data indicate that normal aging associates with 8 
remodelling of lipid contents in cortical lipid rafts. Interestingly, these results are in close 9 
agreement with recent observations in mouse frontal cortex, where aging was demonstrated to 10 
alter the lipid matrix of lipid rafts, including cholesterol reduction, thereby giving rise in 2012 to 11 
the ´lipid raft aging´ hypothesis (Fabelo et al., 2012). Amongst all lipid changes detected in this 12 
study, the reduction of cholesterol contents appears to be the most commonly reported effect 13 
of aging in the brain, and it has been observed in human cortex, hippocampus and cerebellum, 14 
mouse synaptosomes or cultured hippocampal neurons (Martín et al., 2010a; Söderberg et al., 15 
1990; Svennerholm, 1994). It is widely accepted that cholesterol synthesis is very high in the 16 
developing brain, but this rate declines at low and constant levels during adulthood (Dietschy 17 
and Turley, 2004). Cholesterol plays an essential role in establishing physicochemical properties 18 
of lipid rafts and is largely responsible for its liquid-ordered state (Brown and London, 2000; 19 
Díaz et al., 2012). We and others have reported that lipid alterations in lipid rafts severely 20 
impact protein-protein interactions and protein clustering during signal activation, and thereby 21 
modify transduction pathways affecting neuronal physiology (Colin et al., 2016; Frisardi et al., 22 
2010; Martín et al., 2010; Marín et al., 2013; Ohno-Iwashita et al., 2010). For example, it has 23 
been shown the recruitment of NMDA receptors to lipid rafts (where specific kinases that 24 
phosphorylate its subunits - NR1, NR2A, NR2B- are present in larger proportion) in the rat 25 
hippocampus and insular cortex during spatial memory formation. This process is associated to 26 
receptor lateral diffusion within the membrane (Delint-Ramirez et al., 2008), which, in turn, rely 27 
on the composition of lipid rafts. Also, in the CA1 hippocampal area, both LTP and LTD become 28 
impaired by raft disruption as a consequence of cholesterol depletion, which correlates with a 29 















to modifications of AMPA and NMDA responses (Frank et al., 2008; Koudinov and Koudinova, 1 
2001).  2 
Most evidences on the deleterious effects of raft disruption on synaptic transmission and 3 
plasticity reported up to now, derive from artificial manipulations of membrane cholesterol 4 
(with little specificity for membrane domains). Thus, the observation reported here that lipid 5 
rafts cholesterol contents are reduced as part of the normal aging program, at least in the 6 
frontal cortex, is relevant and provides a biochemical support for the modifications on protein-7 
protein dynamics and protein clustering in lipid raft underlying alterations in synaptic plasticity 8 
and memory retention and learning during aging.  9 
Several reports have demonstrated that besides cholesterol, other important lipids undergo a 10 
selective depletion with aging in both human brain and animal models. Amongst the most 11 
important, long chain polyunsaturated fatty acids (LCPUFA) are particularly relevant since they 12 
are highly concentrated in brain membranes. Both n-6 LCPUFA (mainly arachidonic acid) and n-13 
3 LCPUFA (mainly DHA) have been found to be reduced during physiological aging in human 14 
brain (particularly in cortex and hippocampus) (Cutuli, 2016; McNamara et al., 2008).  However, 15 
a recent exhaustive lipid profiling of human frontal cortex demonstrates that fatty acid 16 
contents are basically preserved through the adult lifespan but decay at advanced ages (Cabré 17 
et al., 2017). The onset of lipid alterations occurs at advanced ages, therefore changes do not 18 
occur gradually, and depends on the group of fatty acids. Thus, the increase in saturated fatty 19 
acids begins in the decade following age 70, but the decay in main LCPUFA (arachidonic acid 20 
and DHA) occurs in the decade following age 80 (Cabré et el., 2017). In agreement, in the 21 
present study, the increase in saturates in total phospholipids was observed in older men and 22 
women, but the decline in LCPUFA was only apparent in older women. This is likely due to the 23 
age range used in this study (24-85 years), with only two subjects above the age of 80.  24 
However, our demonstration that these essential fatty acids are affected by aging in frontal 25 
cortex lipid rafts indicates that these microdomains are particularly sensitive and that 26 
alterations in their biogenesis represent early events during normal aging. These findings are 27 
clearly in line with our previous findings demonstrating a dramatic reduction of both n-3 and n-28 
6 LCPUFA in cortical lipid rafts in different neurodegenerative diseases, namely Alzheimer’s 29 
disease, Dementia with Lewy Bodies and Parkinson`s disease (Díaz et al. 2013; Fabelo et al., 30 















double transgenic (APP/PS1) mice model of familial Alzheimer’s disease (Fabelo et al., 2012). 1 
Paralleling the age-associated changes of LCPUFA in non-pathological human brain, lipid raft 2 
alterations are also accompanied by increased sulphatide levels (and total polar lipids) as well 3 
as reduction in cholesterol contents. This is interesting since these features are signs of lipid 4 
raft aging in mice frontal cortex, being this effect exacerbated in the mice model of familial 5 
Alzheimer’s disease (Fabelo et al., 2012). Comparatively, these observations led us to 6 
hypothesize that it may be the depletion of n-3 and n-6 PUFA, cholesterol and probably 7 
plasmalogens, together with the increase of sulphatides, the features that determine the onset 8 
of the neurodegenerative process, at least at the lipid raft level.  9 
Noteworthy, several studies have disclosed alterations in the activity and/or gene expression of 10 
proteins involved in lipid metabolism. For instance, ELOVL2 (encoding for the ELongase Of Very 11 
Long fatty acids 2 protein, one of the critical enzymes involved in the elongation of n-3 and n-6 12 
polyunsaturated fatty acids), undergoes an increase in its methylation level which strongly 13 
correlates with age in healthy volunteers (Steegenga et al., 2014). Further, It has been reported 14 
for the brain cortex that levels of plasmalogens decrease with age, and that the activity of 15 
DHAP-AT (Dihydroxyacetone phosphate acyltransferase, involved in the first step of 16 
plasmalogens biosynthesis) decreases during aging, along with increased activation of Pls-PLA2s 17 
(a specific plasmalogens degradation enzyme, endowed with phospholipase A2 activity (Andrè 18 
et al., 2006). These effects appear to be mediated by epigenetic mechanisms. On the other 19 
hand, protein expression of HMGR (3-hydroxy 3-methyl glutaryl coenzyme A reductase, the key 20 
regulatory enzyme in cholesterol biosynthesis) and LDLr (the low density lipoprotein receptor, 21 
responsible of cellular cholesterol uptake), undergo age-related alterations in different brain 22 
areas, including frontal cortex and hippocampus (Segatto et al., 2013). Interestingly, this same 23 
study demonstrated an age- and sex-dependent reduction of HMGR, with total HMGR protein 24 
levels being lower in female rats than age-matched males, secondary to reduction of 25 
transcriptional processes. 26 
One relevant observation in the present study is the demonstration that lipid modifications are 27 
qualitatively and quantitatively linked to gender. These gender differences extend to both lipid 28 
classes (plasmalogens, sterol esters), fatty acids (saturates 15:0, 22:0, 16:0 DMA, 22:0, 23:0, 29 
monoenes 18:1n-7, 18:1n-9, 18:1n-9 DMA, 18:1n-7 DMA, polyunsaturated 22:6n-3, 22:5n-6, 30 















as independent variable are also different between sexes. These differences were further 1 
confirmed by using partial correlation analyses controlling for gender (Table 3). We used a 2 
multivariate approach in a 3D space using these differential variables to obtain a representative 3 
lipid fingerprint for the lipid rafts from the different groups. The analyses revealed that largest 4 
differences between young and older individuals was more notorious in the case of women, 5 
being the group Women > 60 the best segregated, both for fatty acids and lipid classes. Further, 6 
the outcomes of ANOVA-II analyses applied to factor scores demonstrate significant 7 
interactions between age and gender for fatty acids in both factor scores, and for factor score 2 8 
for lipid classes, which agrees with the fact that most differential features between sexes 9 
occurred in fatty acids. Furthermore, some relevant bivariate relationships between fatty acids 10 
and lipid classes were also altered by the effect of aging in a gender-related manner, indicating 11 
a pronounced alteration of phospholipid acylation-reacylation in older women, while others, 12 
perhaps more critical for membrane homeoviscosity and raft stability (Fig. 4D, G and H), 13 
remained unaltered.  14 
The existence of gender differences in lipid raft composition and the ascertainment that these 15 
alterations are more prominent in older women might be seminal to explain why progression 16 
from mild cognitive impairment to AD is higher in postmenopausal women than in age-matched 17 
men (Alzheimer's Association, 2014; Henderson, 2008; Rettberg et al., 2016). Indeed, according 18 
to Alzheimer's Association (2014), women have a 2-fold greater lifetime risk of developing AD. 19 
Noteworthy, comparison of our present results with those of lipid rafts from early stages of 20 
Alzheimer disease (Fabelo et al., 2014) reveal that, although lipid alterations in AD brains were 21 
much more severe, similar trends to destabilize lipid matrix of lipid rafts were observed in the 22 
frontal cortex from aged brains, particularly in women. Although the biological basis for gender 23 
differences in AD remains to be established, basic science and epidemiological data indicate 24 
that the menopausal transition and decline in estrogen adversely affect brain and whole-body 25 
metabolism (Brinton et al., 2015; Henderson and Brinton, 2010; Henderson, 2008; Rettberg et 26 
al., 2016). Presumably, these lipid alterations will impact synaptic function and protein 27 
interactions and dynamics in signalosomes residing in lipid rafts (see Hara et al., 2015 for a 28 
comprehensive review). In line with this, we have recently observed that aging disrupts the 29 
neuroprotective multiprotein complex estrogen-receptor (ERα)/IGF-1R/VDAC1, which interacts 30 















(Canerina-Amaro et al., 2017). Such disruption displaces protein components towards non-raft 1 
domains in parallel with modifications of raft lipid matrix and leave plasmalemmal VDAC out of 2 
the control of ER, thereby favouring its pro-apoptotic actions (Fernandez-Echevarría et al., 3 
2014; Herrera et al., 2011a; 2011b).   4 
In summary, our lipid profiling study of lipid rafts reveals that aging is accompanied by a 5 
substantial alteration of lipid rafts lipid matrix. This phenomenon, termed “lipid raft aging” 6 
exhibits clear gender differences and appear to be more pronounced in women than in men, 7 
especially in older (postmenopausal) women. The outcomes led us to conclude that human 8 
cortical lipid rafts are modified by aging in a gender-dependent fashion. Given the central role 9 
of bilayer lipid matrix in lipid rafts functionality and neuronal signalling, we hypothesize that 10 
these findings might underlie the higher prevalence of cognitive decline evolving towards 11 
Alzheimer´s disease in postmenopausal women.   12 
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Table 1. Summary of cases 1 
Case  Age Gender  PM delay SNC Primary diseases Immediate diseases Cause of death 
1 38 M 18h NL Diverticulitis, peritonitis Surgical resection  
2 40 M 9h15min NL Sarcoidosis, lung stage IV Respiratory insufficiency Cardiac failure 
3 39 M 3h30min NL AHT, dyslipidemia, obesity Pneumonia Respiratory failure 
4 47 M 4h50min SBVD Ischemic cardiopathy Coronary bypass Massive cardiac infarction 
5 40 M 5h10min NL INA INA INA 
6 44 M 6h40min SBVD AHT, diabetes, obesity Pulmonary thromboembolism Respiratory failure 
7 52 M 3h NL Pancreatic carcinoma Multiple metastasis Hepatic failure 
8 78 M 2h15min SBVD Lung carcinoma Multiple metastasis, pneumonia Respiratory failure 
9 79 M 7h SBVD Cardiomegaly Cardiac infarction Multi-organic failure 
10 85 M 5h45min SBVD Temporal arteritis; ischemic 
cardiopathy 
Coronary bypass Respiratory failure 
11 70 M 13h NL AHT, diabetes, obesity, 
alcoholism, dyslipidemia 
Ischemic heart disease Cardiac and respiratory failure 
12 69 M 7h35min AAII AHT, alcoholism, anemia, 
hepatic cirrhosis 
Hepatorenal transplantation Respiratory failure 
13 71 M 12h NL Gastrectomy Prostate carcinoma Respiratory failure 
14 61 M 3h55min NL AHT, dyslipidemia, COPD Acute hepatitis Multi-organic failure 
15 45 F 14h40min NL AHT, dyslipidemia, COPD Metastatic carcinoma Respiratory failure 
16 24 F 6h NL Ovaric dysgerminoma Renal insufficiency Septic shock 
17 46 F 14h5min NL Diabetes, cardiomyopathy Renal insufficiency Cardiac failure 
18 49 F 7h NL Paraganglioma Small cell carcinoma of the lung Respiratory failure 
19 47 F 9h35min NL INA INA INA 
20 74 F 5h30min NL Renal insufficiency Infectious endocarditis Massive digestive hemorrhage 
21 82 F 11h NL INA INA INA 
22 75 F 3h SBVD Ischemic heart disease Acute heart infarction Cardiac failure 
23 69 F 2h30min NL Alcoholism Double mitral heart disease Cardiac failure 
24 66 F 8h NL Valvular heart disease Intervention Cardiac arrest 
















NL: no lesions; SBVD: small blood vessel disease; AHT: arterial hypertension; AAII: Alzheimer astrocyte type II; COPD: chronic obstructive 1 















Table 2. Summary of the results of lipid rafts lipid composition in younger (<60) and older (>60) 1 
Women and Men.  2 
  
Men < 60 Men > 60 Women < 60 Women > 60 
Age 42,86 ± 1,93 
 
73,29 ± 3,00 
 
42,20 ± 4,11 
 
71,67 ± 2,38 
 
FATTY ACIDS 
14 : 0 0,56 ± 0,05   0,50 ± 0,04   0,51 ± 0,08   0,53 ± 0,05   
15 : 0 0,61 ± 0,19  0,82 ± 0,18  1,21 ± 0,31  0,98 ± 0,14  
16 : 0 DMA 0,59 ± 0,28 a 0,03 ± 0,03 b 0,00 ± 0,00 c 0,00 ± 0,00 c 
16 : 0 26,66 ± 1,48   24,86 ± 1,19   24,57 ± 1,52   22,95 ± 1,84   
16 : 1 0,90 ± 0,07   0,94 ± 0,08   0,99 ± 0,15   1,17 ± 0,11   
16 : 2 0,12 ± 0,04   0,17 ± 0,03   0,23 ± 0,03   0,23 ± 0,02   
17 : 0 0,39 ± 0,04   0,32 ± 0,01   0,32 ± 0,01   0,30 ± 0,02   
18 : 0 DMA 4,14 ± 0,13   4,23 ± 0,19   4,13 ± 0,18   4,15 ± 0,12   
18:1 n-9 DMA 0,14 ± 0,07 a 0,01 ± 0,01 b 0,00 ± 0,00 c 0,00 ± 0,00 c 
18:1 n-7 DMA 0,24 ± 0,12 a 0,02 ± 0,02 b 0,00 ± 0,00 c 0,00 ± 0,00 c 
18 : 0 22,22 ± 0,34   22,50 ± 0,42   21,75 ± 0,53   21,51 ± 0,54   
18:1 n-9 16,02 ± 0,74 b 16,38 ± 1,07 b 17,77 ± 0,63 b 20,16 ± 1,33 a 
18:1 n-7 4,12 ± 0,16 b 5,39 ± 0,42 a 5,00 ± 0,54 ab 4,79 ± 0,35 ab 
18 : 2 n-6 0,95 ± 0,07   0,90 ± 0,12   1,10 ± 0,13   0,78 ± 0,09   
18 : 3 n-3 0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   
20 : 0 0,25 ± 0,03   0,20 ± 0,01   0,18 ± 0,01   0,21 ± 0,01   
20 : 1 0,99 ± 0,14   1,07 ± 0,27   1,28 ± 0,27   1,22 ± 0,20   
20 : 2 n-6 0,05 ± 0,04   0,17 ± 0,05   0,20 ± 0,08   0,13 ± 0,06   
20 : 3 n-6 0,58 ± 0,06   0,50 ± 0,01   0,59 ± 0,08   0,56 ± 0,03   
20 : 4 n-6 4,71 ± 0,36 a 3,90 ± 0,15 ab 3,66 ± 0,14 ab 3,49 ± 0,25 b 
20 : 5 n-3 0,03 ± 0,03   0,07 ± 0,04   0,12 ± 0,05   0,11 ± 0,04   
22:0 0,12 ± 0,05 b 0,20 ± 0,08 a 0,13 ± 0,05 b 0,25 ± 0,04 a 
22 : 1 0,15 ± 0,09   0,36 ± 0,13   0,35 ± 0,05   0,32 ± 0,11   
22 : 2 n-6 0,27 ± 0,11 b 0,63 ± 0,11 ab 0,56 ± 0.08 ab 0,73 ± 0,10 a 
23:0 1,55 ± 0,57 b 2,39 ± 0,10 a 2,41 ± 0,19 a 2,39 ± 0,19 a 
22 : 5 n-6 0,88 ± 0,11 a 0,59 ± 0,08 ab 0,63 ± 0,16 ab 0,42 ± 0,07 b 
22 : 5 n-3 0,07 ± 0,03   0,15 ± 0,04   0,04 ± 0,04   0,11 ± 0,03   
22 : 6 n-3 7,91 ± 0,36 a 6,83 ± 0,62 ab 6,28 ± 0,31 ab 6,59 ± 0,25 b 
24:0 0,22 ± 0,09   0,12 ± 0,05   0,10 ± 0,06   0,36 ± 0,15   
24 : 1 n-9 0,69 ± 0,11   1,37 ± 0,23   1,47 ± 0,34   1,20 ± 0,23   
Totals and indexes 
Saturates 57,30 ± 1,27   56,16 ± 1,57   55,32 ± 1,53   53,63 ± 2,11   
Unsaturated 40,25 ± 0,96   39,82 ± 0,96   40,06 ± 0,85   41,25 ± 1,25   
DMAs 5,10 ± 0,40   4,29 ± 0,19   4,13 ± 0,18   4,15 ± 0,12   
n-9 16,86 ± 0,70   17,76 ± 1,26   19,24 ± 0,93   20,36 ± 1,33   
n-3 8,01 ± 0,33 a 7,05 ± 0,67 ab 6,04 ± 0,50 b 6,80 ± 0,26 ab 
n-6 8,66 ± 0,86 a 6,75 ± 0,26 ab 6,74 ± 0,30 ab 6,11 ± 0,29 b 
n-3 LCPUFA 7,98 ± 0,35 a 6,98 ± 0,65 ab 5,92 ± 0,47 b 6,69 ± 0,26 ab 















18:1n-9/n-3 LCPUFA 2,04 ± 0,16 b 2,59 ± 0,40 ab 3,13 ± 0,34 a 2,87 ± 0,20 ab 
Monoenoic 23,40 ± 0,88  25,84 ± 1,41  27,05 ± 1,37  28,11 ± 1,39  
PIx 90,11 ± 5,65 a 74,90 ± 5,61 b 66,71 ± 4,34 b 70,63 ± 2,54 b 
UIx 104,09 ± 5,18 a 91,97 ± 3,50 b 86,87 ± 2,07 b 90,16 ± 2,13 b 
saturates/unsaturates 1,43 ± 0,06   1,42 ± 0,07   1,39 ± 0,07   1,32 ± 0,09   
saturates/n-3 7,23 ± 0,32 b 8,43 ± 0,68 ab 9,40 ± 0,60 a 7,98 ± 0,52 ab 
saturates/n-9 3,45 ± 0,22   3,31 ± 0,32   2,92 ± 0,21   2,75 ± 0,29   
LIPID CLASSES 
LPC 0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   
SM 8,95 ± 1,90   12,93 ± 1,08   12,40 ± 1,71   9,78 ± 2,01   
PC 5,63 ± 0,33   5,32 ± 0,67   4,30 ± 0,65   5,26 ± 0,46   
PS 7,36 ± 0,29  7,09 ± 0,70  6,35 ± 0,23  6,30 ± 0,44  
PI 2,47 ± 0,14  2,20 ± 0,27  2,12 ± 0,10  2,02 ± 0,13  
PG 0,90 ± 0,16   0,79 ± 0,09   0,53 ± 0,14   0,61 ± 0,14   
PE 20,87 ± 0,51   20,24 ± 0,30   19,51 ± 0,97   21,58 ± 0,87   
Sulphatides 8,57 ± 1,03 b 9,94 ± 0,92 ab 10,12 ± 0,83 ab 11,44 ± 0,57 a 
Cerebrosides 3,97 ± 1,04 a 3,89 ± 0,52 ab 4,86 ± 1,16 ab 6,27 ± 1,05 a 
DAG 0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   
Cholesterol 36,92 ± 2,14   33,91 ± 1,13   36,79 ± 2,25   33,01 ± 1,78   
FFA 1,87 ± 0,32   2,29 ± 0,33   1,89 ± 0,25   1,96 ± 0,33   
TG 0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   0,00 ± 0,00   
SE 2,47 ± 0,90   1,37 ± 0,72   1,13 ± 0,62   1,74 ± 0,74   
Totals 
TNL 41,25 ± 2,06   37,57 ± 1,20   39,82 ± 1,51   36,71 ± 2,13   
TPL 58,72 ± 2,05   62,41 ± 1,21   60,18 ± 1,51   63,27 ± 2,12   
 1 
Results are expressed as mean ± SEM. Different letters in the same row indicate statistical differences with p-2 
values < 0.05. DMA: Dimethylacetals, LCPUFA: Long-chain polyunsaturated fatty acids, PIx: Peroxydability 3 
index, UIx: unsaturation index LPC: Lyso-phosphatidylcholine, SM: Sphingomyelin, PC: Phosphatidylcholine, PS: 4 
Phosphatidylserine, PI: Phosphatidylinositol, PG: Phosphatidylglycerol, PE: Phosphatidylethanolamine, DAG: 5 
Diacylglycerides, FFA: Free fatty acids, TG: Triglycerides, SE: sterol esters, TNL: Total neutral lipids, TPL: Total 6 
















Table 3. Correlation analyses for all lipid variables in pooled data (Women + Men), partial 1 
correlations (controlling for sex), and Pearson correlations for separated gender.  2 
Gender 
  Total Pooled Partial Men Women 
Fatty acid Pearson  Correlations Pearson  Pearson  
14 : 0 -0,147   -0,147   -0,359   0,042   
15 : 0 -0,025   -0,029   0,099   -0,166   
16 : 0 DMA -0,282   -0,298   -0,399  (a) # 
16 : 0 -0,176   -0,180   -0,261  -0,098   
16 : 1 0,134   0,140   0,012  0,242   
16 : 2 0,116   0,127   0,261  -0,139   
17 : 0 -0,265   -0,280   -0,386  -0,049   
18 : 0 DMA 0,158   0,158   0,197  0,103   
18:1 n-9 DMA -0,235   -0,246   -0,33  (a) # 
18:1 n-7 DMA -0,262   -0,277 -0,371  (a) # 
18 : 0 -0,028   -0,027   0,057  -0,107   
18:1 n-9 0,161   0,175   0,09   0,425   
18:1 n-7 0,127   0,127   0,559 * -0,402   
18 : 2 n-6 -0,363 * -0,367 * -0,135   -0,602 # 
20 : 0 -0,146   -0,150   -0,362   0.,638 * 
20 : 1 -0,011   -0,012   0,143   -0,206   
20 : 2 n-6 0,083   0,083   0,45 -0,279   
20 : 3 n-6 -0,385 * -0,389 * -0,421 # -0,361   
20 : 4 n-6 -0,242   -0,271   -0,415 # -0,002   
20 : 5 n-3 0,141   0,145   0,243   0,044   
22:0 0,233   0,233   0,092   0,492 
22 : 1 0,063   0,062   0,277   -0,324   
22 : 2 n-6 0,403 # 0,425 # 0,459 # 0,379   
23:0 0,193   0,197   0,288   -0,019   
22 : 5 n-6 -0,321  -0,341 * -0,431  -0,232   
22 : 5 n-3 0,370 * 0,375 * 0,325  0,444   
24:0 0,063   0,063   -0,289   0,347   
22 : 6 n-3 -0,110   -0,117   -0,316   0,365   
24 : 1 n-9 0,162   0,165   0,687 * -0,378   
  Total Pooled Partial Men Women 
Lipid Index Pearson  Correlations Pearson  Pearson  
Saturates -0,148   -0,152   -0,214   -0,092   
Unsaturates 0,091   0,091   0,039   0,15   
DMAs -0,192   -0,204   -0,323   0,103   
n-9 0,173   0,188   0,212   0,163   
n-3 0,062   0,070   -0,27   0,693 * 
n-6 -0,343 * -0,373 * -0,424  -0,331   
n-3 LCPUFA 0,052   0,060   -0,29  0,707 * 
n-3/n-6 0,418 # 0,418 # 0,184  0,714 * 
18:1n-9/n-3 LCPUFA 0,021   0,020   0,303  -0,424 
Monoenoic 0,198   0,216   0,397  -0,003   















UIx -0,107   -0,116   -0,369  0,611 # 
saturates/unsaturates -0,113   -0,114   -0,124   -0,104   
saturates/n-3 -0,151   -0,159   0,312   -0,736 * 
saturates/n-9 -0,120   -0,127   -0,147   -0,102   
  Total Pooled Partial Men Women 
Lipid classes Pearson  Correlations Pearson  Pearson  
LPC NA   NA   NA   NA   
SM 0,110   0,110   0,476 * -0,315   
PC 0,054   0,057   -0,237   0,409  
PS -0,011   -0,009   -0,057   0,082  
PI -0,202   -0,209   -0,229   -0,194  
PG 0,053   0,059   -0,149   0,318  
PE 0,216   0,216   -0,299   0,533 # 
Sulphatides 0,309 # 0,326 0,287   0,411 # 
Cerebrosides 0,143   0,150   -0,021   0,316  
Cholesterol -0,357 * -0,358 * -0,28   -0,446  
FFA 0,083   0,084   0,11   0,046  
SE -0,162   -0,162   -0,322   0,086  
TNL -0,416 * -0,419 * -0,404 # -0,437 * 
TPL 0,416 * 0,419 * 0,405 # 0,437 * 
Statistical differences: * p<0.01, # p<0.05 1 
Results are expressed as mean ± SEM. Different letters in the same row indicate statistical differences 2 
with p-values below 0.01 (*) or 0.05 (#). DMA: Dimethylacetals, LCPUFA: Long-chain polyunsaturated 3 
fatty acids, PIx: Peroxydability index, UIx: unsaturation index LPC: Lyso-phosphatidylcholine, SM: 4 
Sphingomyelin, PC: Phosphatidylcholine, PS: Phosphatidylserine, PI: Phosphatidylinositol, PG: 5 
Phosphatidylglycerol, PE: Phosphatidylethanolamine, FFA: Free fatty acids, SE: sterol esters, TNL: Total 6 
neutral lipids, TPL: Total polar lipids. 7 















Table 4. Lipid composition of frontal brain cortex from young (< 60 years, n=10) and older (> 1 
60 years, n=11) Men and Women. 2 
 3 
 
Men < 60 
 
Men  > 60 
 
Women < 60 
 
Women > 60 
 FATTY ACIDS 
14 : 0 0,35 ± 0,05 0,34 ± 0,03 0,34 ± 0,04 0,40 ± 0,02 
15 : 0 0,56 ± 0,10 0,69 ± 0,22 0,59 ± 0,08 0,63 ± 0,06 
16 : 0 18,89 ± 1,15 19,78 ± 0,35 20,19 ± 2,55 22,30 ± 1,51 
16 : 11 1,32 ± 0,21 1,00 ± 0,14 1,25 ± 0,21 2,70 ± 0,86 
16 : 4 4,33 ± 0,45 a 4,45 ± 0,39 a 4,48 ± 1,00 a 2,86 ± 0,80 b 
18 : 0 21,57 ± 0,69 23,98 ± 0,91 23,92 ± 1,29 25,06 ± 1,61 
18: 1 n-9 14,64 ± 2,12 13,45 ± 1,54 16,81 ± 2,46 18,09 ± 2,53 
18: 1 n-7 7,29 ± 0,77 6,77 ± 0,69 7,31 ± 1,46 7,34 ± 1,00 
18 : 2 n-6 0,56 ± 0,14 0,87 ± 0,41 0,78 ± 0,49 0,43 ± 0,07 
20 : 12 1,26 ± 0,47 0,90 ± 0,30 1,34 ± 0,66 1,36 ± 0,50 
20 : 3 n-6 0,71 ± 0,09 0,56 ± 0,03 0,45 ± 0,27 0,44 ± 0,13 
20 : 4 n-6 5,06 ± 0,78 4,01 ± 0,71 3,23 ± 0,70 2,37 ± 0,76 
20 : 5 n-3 0,16 ± 0,09 0,85 ± 0,32 0,38 ± 0,40 0,23 ± 0,05 
22: 0 0,37 ± 0,15 b 1,30 ± 0,42 a 0,60 ± 0,68 ab 0,27 ± 0,11 b 
22 : 2 n-6 0,62 ± 0,12 b 1,97 ± 0,59 a 0,89 ± 1,02 ab 0,39 ± 0,06 b 
22 : 4 n-6 3,69 ± 0,17 3,25 ± 0,42 2,68 ± 0,69 2,09 ± 0,55 
22 : 5 n-6 0,73 ± 0,19 0,46 ± 0,22 0,37 ± 0,11 0,18 ± 0,17 
24: 0 0,37 ± 0,08 0,32 ± 0,05 0,43 ± 0,20 0,36 ± 0,09 
22 : 6 n-3 7,46 ± 1,09 a 5,63 ± 1,13 ab 6,41 ± 1,36 5,57 ± 1,01 
24 : 1 n-9 1,24 ± 0,38 1,13 ± 0,33 1,36 ± 0,61 1,34 ± 0,47 
Totals and indexes 
Saturates 42,50 ± 1,64 46,87 ± 1,22 46,48 ± 3,29 49,55 ± 3,03 
n-9 15,88 ± 2,32 14,44 ± 1,48 18,17 ± 2,91 19,44 ± 2,82 
n-3 7,81 ± 1,17 6,70 ± 0,86 7,34 ± 1,18 7,49 ± 0,86 
n-6 11,56 ± 1,11 a 11,34 ± 1,27 a 9,02 ± 1,50 a 6,86 ± 1,68 b 
n-3 LCPUFA 7,81 ± 1,17 6,70 ± 0,86 6,79 ± 1,18 5,80 ± 0,86 
n-3/n-6 0,68 ± 0,08 0,59 ± 0,13 0,81 ± 0,14 1,09 ± 0,10 
18:1/n-3 H 1,88 ± 0,53 2,01 ± 0,07 2,48 ± 1,06 3,12 ± 1,08 
Saturates/n-3 5,45 ± 0,38 7,00 ± 1,02 6,34 ± 0,69 6,62 ± 0,83 
Saturates /n-9 2,68 ± 0,25 3,25 ± 0,35 2,56 ± 0,29 2,55 ± 0,32 
LIPID CLASSES 
LPC 0,00 ± 0,00  0,00 ± 0,00  0,00 ± 0,00  0,00 ± 0,00  
SM 3,52 ± 0,30 4,20 ± 0,50 3,74 ± 0,72 3,80 ± 0,60 
PC 9,29 ± 1,04 8,32 ± 0,73 8,03 ± 1,93 8,33 ± 1,44 
PS 8,18 ± 1,33 8,93 ± 0,83 7,99 ± 1,70 9,22 ± 0,73 
PI 2,98 ± 1,21 3,23 ± 0,35 2,11 ± 0,75 3,60 ± 0,74 
PG 0,73 ± 0,42 1,41 ± 0,22 1,37 ± 0,53 0,68 ± 1,52 















Sulphatides 12,07 ± 2,17 11,85 ± 1,78 12,16 ± 2,71 12,26 ± 1,13 
Cerebrosides 5,60 ± 1,77 6,09 ± 1,51 6,79 ± 2,58 6,94 ± 1,85 
DAG 0,00 ± 0,00 0,00 ± 0,00 0,00 ± 0,00 0,00 ± 0,00 
CHO 29,64 ± 1,01 30,07 ± 1,63 31,26 ± 0,97 27,77 ± 1,76 
FFA 3,21 ± 0,73 3,05 ± 0,68 3,74 ± 0,75 1,61 ± 1,15 
TG 0,00 ± 0,00 0,00 ± 0,00 0,00 ± 0,00 0,00 ± 0,00 
SE 2,16 ± 1,08 1,68 ± 0,51 1,22 ± 0,43 2,87 ± 1,47 
Totals 
TNL 52,68 ± 3,02 52,73 ± 0,97 55,17 ± 4,91 51,45 ± 2,48 
TPL 47,32 ± 3,02 47,27 ± 0,97 44,83 ± 4,91 48,55 ± 2,48 
 1 
Results are expressed as mean ± SEM. Different letters in the same row indicate statistical differences 2 
with p-values below 0.05. 
1 
Contains n-9 and n-7 isomers. 
2 
Contains n-11 and n-9 isomers. Totals 3 
include some minor components not shown. DMA: Dimethylacetals, LCPUFA: Long-chain 4 
polyunsaturated fatty acids, PIx: Peroxydability index, UIx: unsaturation index LPC: Lyso-5 
phosphatidylcholine, SM: Sphingomyelin, PC: Phosphatidylcholine, PS: Phosphatidylserine, PI: 6 
Phosphatidylinositol, PG: Phosphatidylglycerol, PE: Phosphatidylethanolamine, DAG: Diacylglycerides, 7 















Figure 1. Age-associated changes in lipid rafts in a subset of lipid groups, indexes and lipid classes in healthy (control) women and men. A and B: 1 
















Figure 2. Score plots from Principal Component Analyses for lipid classes in all groups according to age-gender pairs (A: Age 1 
and B: Gender, for PC1 and PC2) and C for all groups in a 3-D space. D and E analyses of age-gender interactions in factor 2 



















Figure 3. Score plots from Principal Component Analyses for fatty acids in all groups according to age-gender pairs (A: Age 1 
and B: Gender for PC1 and PC2) and C for all groups in a 3-D space. D and E analyses of age-gender interactions in factor 2 
scores 1 and 2. For details see results. 3 
 4 















Figure 4. Bivariate regression lines between different groups of lipids from frontal cortex lipid rafts in women and men. For 1 















































































Saturates 1,000 -,973(**) -0,544 -,916(**) 0,145 0,566 0,164 -0,270 -,739(**) -,947(**) 0,337 -0,083 ,984(**) 0,277 ,922(**) 0,288 -0,289
Unsaturates -,771(**) 1,000 0,534 ,953(**) -0,057 -0,573 -0,075 0,336 ,704(*) ,947(**) -0,263 0,170 -,996(**) -0,343 -,970(**) -0,440 0,442
DMAs -0,048 ,548(*) 1,000 0,537 -0,174 0,103 -0,162 -0,186 0,461 0,450 -0,108 0,166 -0,559 -0,059 -0,548 0,222 -0,222
n-9 -,896(**) ,581(*) -0,194 1,000 -0,033 -,665(*) -0,069 0,398 ,722(*) ,926(**) -0,262 0,143 -,949(**) -0,358 -,989(**) -0,489 0,490
n-3 0,458 -0,007 0,401 -,656(*) 1,000 -0,077 ,994(**) ,791(**) -,698(*) -0,313 ,933(**) ,905(**) 0,120 -,903(**) 0,070 -,630(*) ,629(*)
n-6 0,191 0,434 ,833(**) -0,374 ,589(*) 1,000 -0,046 -,659(*) -0,398 -,669(*) 0,272 0,084 0,562 0,339 ,608(*) 0,553 -0,555
n-3 LCPUFA 0,452 0,008 0,434 -,661(*) ,998(**) ,615(*) 1,000 ,762(**) -,728(*) -0,334 ,940(**) ,906(**) 0,136 -,885(**) 0,095 -0,597 0,596
n-3/n-6 0,242 -0,495 -0,516 -0,227 0,325 -,560(*) 0,297 1,000 -0,264 0,196 0,531 ,637(*) -0,280 -,897(**) -0,334 -,813(**) ,814(**)
18:1n-9/n-3 LCPUFA -,737(**) 0,338 -0,333 ,879(**) -,910(**) -0,491 -,913(**) -0,362 1,000 ,855(**) -,816(**) -0,512 -,741(**) 0,370 -,738(**) 0,073 -0,072
Monoenoic -,876(**) 0,489 -0,250 ,930(**) -,786(**) -0,512 -,789(**) -0,191 ,932(**) 1,000 -0,540 -0,143 -,959(**) -0,095 -,936(**) -0,304 0,306
PIx 0,365 0,210 ,649(*) -,587(*) ,934(**) ,835(**) ,946(**) -0,017 -,823(**) -,738(**) 1,000 ,903(**) 0,315 -,756(**) 0,281 -0,388 0,387
UIx 0,186 0,418 ,759(**) -0,427 ,841(**) ,906(**) ,857(**) -0,189 -,679(**) -,584(*) ,973(**) 1,000 -0,117 -,896(**) -0,137 -0,555 0,554
saturates/unsaturates ,943(**) -,935(**) -0,299 -,793(**) 0,239 -0,114 0,229 0,368 -,572(*) -,725(**) 0,083 -0,120 1,000 0,290 ,967(**) 0,377 -0,379
saturates/n-3 -0,270 -0,104 -0,436 0,472 -,951(**) -0,509 -,952(**) -0,387 ,826(**) ,638(*) -,877(**) -,805(**) -0,077 1,000 0,316 ,730(*) -,731(*)
saturates/n-9 ,927(**) -,660(*) 0,142 -,981(**) 0,523 0,298 0,526 0,174 -,794(**) -,885(**) 0,458 0,297 ,855(**) -0,326 1,000 0,484 -0,485
TNL 0,362 0,063 ,682(**) -0,400 0,076 ,660(*) 0,114 -,634(*) -0,253 -0,364 0,337 0,397 0,181 0,013 0,430 1,000 -1,000(**)
TPL -0,361 -0,064 -,679(**) 0,396 -0,071 -,657(*) -0,109 ,637(*) 0,248 0,360 -0,333 -0,393 -0,180 -0,019 -0,427 -1,000(**) 1,000













































































































14 : 0 1,000 0,6 (a) ,650(*) ,874(**) -,773(**) 0,044 -,829(**) (a) (a) -0,135 -0,362 -0,468 0,321 0,451 -,683(*) -,849(**) -0,233 0,198 0,374
15 : 0 0,49 1,000 (a) 0,337 0,556 -0,238 0,112 -0,547 (a) (a) -0,375 -0,31 -0,203 0,165 -0,083 -0,54 -,645(*) -0,374 0,218 -0,101
16 : 0 DMA 0,05 -,560(*) 1,000 (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a)
16 : 0 0,447 -0,353 0,504 1,000 0,365 -,805(**) ,666(*) -,635(*) (a) (a) 0,555 -,860(**) -0,338 0,583 0,312 -,699(*) -0,599 -0,032 0,576 -0,066
16 : 1 ,648(*) ,699(**) -0,311 0,067 1,000 -0,568 -0,086 -,607(*) (a) (a) -0,428 -0,039 -0,523 0,074 0,53 -0,436 -,846(**) -0,254 -0,065 0,307
16 : 2 -0,202 0,331 -,744(**) -,740(**) -0,066 1,000 -0,322 0,561 (a) (a) -0,248 0,453 ,703(*) -0,35 -0,459 ,688(*) ,775(**) 0,381 -0,506 -0,434
17 : 0 0,267 -0,447 ,921(**) ,633(*) -0,235 -,681(**) 1,000 -0,226 (a) (a) ,604(*) -,653(*) -0,138 0,561 -0,069 -0,299 -0,118 0,199 0,353 -0,402
18 : 0 DMA -0,383 0,117 -0,363 -,681(**) -0,207 0,465 -0,519 1,000 (a) (a) -0,051 0,487 0,029 -0,509 -0,312 0,503 0,574 -0,046 -0,001 -0,152
18:1 n-9 DMA -0,179 -0,526 ,880(**) 0,275 -0,243 -,671(**) ,749(**) -0,304 1,000 (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a)
18:1 n-7 DMA -0,112 -,554(*) ,939(**) 0,359 -0,274 -,713(**) ,833(**) -0,323 ,985(**) 1,000 (a) (a) (a) (a) (a) (a) (a) (a) (a) (a)
18 : 0 -0,087 -0,355 0,05 ,628(*) -0,059 -0,495 0,116 -0,352 0,052 0,071 1,000 -,726(*) 0,187 0,512 0,072 -0,239 0,207 0,395 0,53 -0,354
18:1 n-9 -0,184 0,428 -0,425 -,811(**) 0,049 ,771(**) -0,494 0,398 -0,321 -0,374 -,841(**) 1,000 -0,075 -,607(*) -0,145 0,589 0,298 -0,163 -0,598 0,393
18:1 n-7 -0,149 0,304 -0,269 -0,152 0,049 0,095 -0,209 0,044 -0,31 -0,291 0,131 -0,02 1,000 0,101 -0,237 0,537 ,659(*) 0,602 -0,427 -0,494
18 : 2 n-6 0,207 -0,221 0 0,356 0,322 -0,306 -0,088 -0,282 0,019 -0,004 0,325 -0,324 -,533(*) 1,000 -0,269 -0,235 -0,038 0,501 0,228 -0,049
20 : 0 0,486 -0,194 ,613(*) ,549(*) -0,181 -0,474 ,658(*) -0,31 0,208 0,337 -0,092 -0,295 -0,15 0,089 1,000 -0,237 -0,562 -0,24 -0,064 0,117
20 : 1 -0,377 0,202 -0,085 -,817(**) -0,274 ,546(*) -0,19 0,497 0,007 -0,025 -,828(**) ,820(**) 0,187 -,610(*) -0,138 1,000 ,651(*) 0,331 -,737(**) -0,122
20 : 2 n-6 -,734(**) -0,139 -0,456 -,570(*) -,535(*) ,617(*) -,560(*) 0,424 -0,408 -0,433 -0,18 0,505 0,367 -0,31 -0,322 0,531 1,000 0,597 -0,308 -0,229
20 : 3 n-6 -0,043 -0,504 0,374 ,539(*) -,623(*) -0,249 0,456 -0,178 0,105 0,214 0,371 -0,381 -0,188 -0,135 0,505 -0,289 0,053 1,000 -0,292 -0,357
20 : 4 n-6 -0,354 -,841(**) ,690(**) 0,481 -,579(*) -,567(*) ,534(*) -0,18 ,664(**) ,685(**) 0,42 -0,501 -0,454 0,225 0,263 -0,328 -0,116 ,628(*) 1,000 -0,137
20 : 5 n-3 0,352 0,007 -0,296 0,186 0,448 0,092 -0,181 -0,196 -0,266 -0,283 0,071 -0,106 -0,304 ,671(**) -0,079 -0,39 -0,216 -0,357 -0,286 1,000
22:0 ,567(*) ,776(**) -0,514 -0,023 ,717(**) 0,01 -0,381 -0,067 -0,463 -0,492 0,113 -0,09 0,212 0,212 -0,134 -0,28 -0,351 -0,461 -,660(*) 0,32
22 : 1 0,476 ,853(**) -0,438 -0,176 ,703(**) 0,017 -0,352 0,151 -0,393 -0,418 -0,122 0,067 0,37 -0,052 -0,124 -0,003 -0,272 -,572(*) -,754(**) 0,178
22 : 2 n-6 0,102 ,693(**) -,734(**) -0,521 0,33 0,453 -,676(**) 0,345 -,659(*) -,701(**) -0,23 0,346 0,404 -0,055 -0,262 0,263 0,288 -,535(*) -,819(**) 0,238
23:0 -0,159 0,466 -,959(**) -,577(*) 0,134 ,772(**) -,944(**) 0,499 -,865(**) -,920(**) -0,086 0,465 0,18 -0,003 -,554(*) 0,155 ,550(*) -0,255 -,555(*) 0,149
22 : 5 n-6 -0,332 -0,512 ,551(*) -0,094 -0,417 -0,25 0,351 -0,119 ,723(**) ,665(**) -0,178 0,036 -,545(*) 0,226 0,115 0,219 -0,055 0,044 ,584(*) -0,165
22 : 5 n-3 0,108 0,137 -,571(*) 0,282 0,419 0,09 -0,461 -0,167 -0,509 -,541(*) ,613(*) -0,312 0,107 0,388 -0,458 -,682(**) -0,042 -0,096 -0,17 0,491
24:0 ,590(*) ,587(*) -0,042 -0,191 ,626(*) 0,029 0,061 0,026 0,081 0,048 -0,327 0,139 -0,246 0,022 -0,102 0,064 -,666(**) -0,51 -0,442 0,188
22 : 6 n-3 -0,037 -,647(*) 0,497 0,475 -0,156 -0,495 0,449 -0,176 ,571(*) ,561(*) 0,5 -,645(*) -,571(*) 0,446 0,014 -,572(*) -0,515 0,227 ,714(**) 0,185
24 : 1 n-9 -,651(*) -0,095 -0,306 -,566(*) -0,275 0,41 -0,434 0,359 -0,169 -0,218 -0,322 0,479 0,373 -0,182 -0,325 ,588(*) ,794(**) -0,343 -0,26 0,086
SM -0,314 -0,037 -,618(*) -0,144 -0,203 0,421 -,586(*) 0,194 -,542(*) -,594(*) 0,159 0,116 -0,076 0,221 -0,321 -0,106 0,529 0,046 -0,132 0,403
PC 0,463 -0,124 -0,036 ,624(*) 0,394 -0,23 0,1 -,571(*) -0,148 -0,108 ,583(*) -0,506 -0,201 ,635(*) 0,091 -,820(**) -0,442 0,144 0,124 0,497
PS -0,06 -,665(**) 0,197 0,472 -0,148 -0,293 0,176 -0,113 0,154 0,175 ,635(*) -,671(**) -0,285 ,550(*) 0,008 -,671(**) -0,233 0,219 0,53 0,37
PI 0,283 -,562(*) 0,36 ,796(**) -0,06 -,538(*) 0,466 -0,44 0,241 0,293 ,674(**) -,837(**) -0,384 ,575(*) 0,319 -,835(**) -0,512 0,404 0,522 0,456
PG 0,183 -0,461 0,173 ,561(*) -0,217 -0,095 0,321 -0,215 -0,126 -0,001 0,275 -0,341 0,018 0,044 0,409 -0,346 0,028 ,603(*) 0,257 0,211
PE 0,251 0,054 0,059 -0,267 0,112 0,142 0,069 0,275 0,085 0,086 -0,217 -0,009 -0,13 -0,001 -0,017 0,129 -0,335 -0,305 -0,148 0,07
SULFATIDES -0,107 ,630(*) -0,405 -,820(**) 0,29 ,615(*) -0,451 0,372 -0,226 -0,3 -,738(**) ,833(**) 0,325 -0,492 -0,445 ,785(**) 0,302 -,680(**) -,688(**) -0,181
CEREBROSIDES 0,212 ,704(**) -0,272 -,709(**) 0,411 0,491 -0,287 0,352 -0,142 -0,201 -,772(**) ,714(**) 0,056 -0,36 -0,254 ,653(*) -0,065 -,651(*) -,650(*) -0,127
CHO -0,332 -,566(*) ,769(**) 0,313 -,613(*) -,537(*) ,617(*) -0,169 ,619(*) ,681(**) 0,115 -0,26 0,062 -0,253 0,503 0,095 0,081 ,589(*) ,720(**) -,690(**)
FFA 0,52 ,723(**) -,654(*) 0,126 ,778(**) 0,12 -0,491 -0,177 -,638(*) -,655(*) 0,237 -0,026 0,216 0,225 -0,264 -0,429 -0,214 -0,28 -,594(*) 0,36












































































14 : 0 0,566 0,515 -0,504 -0,588 -0,071 0,53 0,187 0,153 -0,449 -,625(*) 0,586 0,228 0,051 0,138 0,404 0,404 0,431 -0,569 ,648(*) ,854(**)
15 : 0 0,511 0,526 -0,284 -0,328 0,19 -0,158 0,291 0,162 -0,374 -0,358 0,573 -0,009 0,349 0,148 0,058 -0,117 0,229 -0,276 0,535 ,727(*)
16 : 0 DMA (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a)
16 : 0 0,179 0,129 -,609(*) -,704(*) 0,351 0,445 -0,551 0,003 -0,212 -0,2 0,365 0,444 -0,15 0,41 -0,205 0,162 -0,253 -0,091 0,505 0,557
16 : 1 ,673(*) 0,444 -0,4 -0,485 -0,236 0,504 0,41 0,175 -0,272 -,769(**) ,703(*) 0,124 0,022 0,294 0,581 0,592 ,602(*) -,698(*) ,684(*) ,839(**)
16 : 2 -0,277 -0,053 0,55 0,483 -0,213 -,688(*) 0,189 -0,025 0,347 0,394 -0,51 -,616(*) -0,097 -0,453 -0,24 -0,315 -0,103 0,482 -,648(*) -0,586
17 : 0 -0,271 -0,331 -0,502 -0,565 0,52 0,202 -,656(*) 0,151 0,029 0,226 0,134 0,161 -0,267 ,607(*) -0,395 0,023 -0,396 0,072 0,088 0,027
18 : 0 DMA -0,295 -0,447 0,446 ,802(**) 0,136 -0,464 -0,052 -0,165 0,332 0,184 -0,289 0,149 0,123 -0,009 -0,131 -0,276 -0,326 0,467 -0,32 -,646(*)
18:1 n-9 DMA (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a)
18:1 n-7 DMA (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a) (a)
18 : 0 -0,403 -0,197 -0,29 -0,208 0,469 0,124 -,800(**) -0,071 0,065 0,405 -0,176 0,38 -0,198 0,095 -,614(*) -0,23 -,771(**) 0,462 -0,133 -0,158
18:1 n-9 -0,067 -0,284 0,446 0,523 -0,512 -0,021 ,624(*) 0,123 0,129 -0,023 -0,14 -0,312 0,133 -0,174 0,539 0,228 0,575 -0,334 -0,325 -0,431
18:1 n-7 -0,334 0,206 0,319 0,027 -0,218 -0,502 -0,12 -0,255 0,416 0,584 -,642(*) -,637(*) -0,243 -0,554 -0,55 -0,366 -0,323 0,551 -0,551 -0,35
18 : 2 n-6 -0,485 0,208 -,855(**) -0,447 0,445 0,144 -0,479 0,057 0,073 0,227 0,011 0,167 0,073 0,071 -0,389 -0,102 -0,288 0,05 0,105 0,174
20 : 0 ,662(*) 0,173 0,149 -0,375 -0,297 0,523 0,169 -0,196 -0,112 -0,507 0,305 0,121 -0,369 0,289 0,384 0,464 0,21 -0,333 0,475 0,527
20 : 1 -0,469 -0,3 0,358 0,272 -0,431 -0,263 0,032 -0,371 ,794(**) 0,466 -,603(*) -0,518 -0,18 -0,125 -0,173 0,022 -0,006 0,192 -0,458 -,624(*)
20 : 2 n-6 -,716(*) -0,32 0,346 0,475 -0,06 -0,447 -0,214 -0,008 0,347 ,653(*) -,773(**) -0,394 -0,183 -0,521 -0,369 -0,322 -0,316 0,595 -,870(**) -,896(**)
20 : 3 n-6 -0,522 0,028 -0,27 -0,194 -0,134 -0,026 -0,402 0,18 0,338 0,323 -0,409 -0,348 -0,456 -0,366 -0,355 0,145 -0,234 0,362 -0,564 -0,351
20 : 4 n-6 0,059 -0,044 -0,342 0,079 ,662(*) 0,023 -0,447 0,162 -0,395 -0,057 0,443 ,832(**) 0,426 0,207 -0,329 -0,331 -0,563 0,191 0,311 0,245
20 : 5 n-3 0,059 0,108 -0,035 0,177 -0,116 0,35 0,448 -0,056 -0,368 -0,363 -0,075 0,119 0,143 -0,168 ,727(*) 0,184 ,630(*) -0,449 0,179 0,056
22:0 1,000 0,469 0,271 -0,185 -0,238 0,104 0,477 -0,019 -0,42 -,784(**) 0,521 0,036 -0,099 0,102 0,481 0,268 0,396 -0,282 0,578 ,737(**)
22 : 1 ,891(**) 1,000 -0,106 -0,036 0,09 -0,34 0,397 -0,264 -0,253 -0,493 0,087 -0,106 0,12 -0,412 0,123 -0,248 0,153 0,137 0,441 ,665(*)
22 : 2 n-6 ,735(**) ,772(**) 1,000 0,435 -0,386 -0,368 0,369 -0,229 -0,036 0,069 -0,44 -0,445 -0,245 -0,353 0,163 -0,182 0,127 0,264 -0,362 -0,371
23:0 0,406 0,316 ,687(**) 1,000 0,219 -0,585 0,305 -0,136 -0,032 0,057 -0,251 0,191 0,464 -0,377 0,059 -0,531 -0,146 0,395 -0,229 -0,448
22 : 5 n-6 -0,419 -0,504 -0,384 -0,422 1,000 -0,359 -0,287 -0,097 -0,225 0,064 0,131 0,541 0,404 0,275 -0,334 -,655(*) -0,546 0,372 0,306 0,096
22 : 5 n-3 0,388 0,198 0,151 0,45 -,591(*) 1,000 -0,116 0,363 -0,138 -0,18 0,384 0,225 -0,239 0,371 0,392 ,791(**) 0,361 -,730(*) 0,137 0,202
24:0 ,564(*) ,557(*) 0,247 -0,038 0,02 -0,122 1,000 0,113 -0,389 -0,432 0,184 -0,329 0,251 -0,239 ,737(**) 0,026 ,752(**) -0,453 0,143 0,252
22 : 6 n-3 -0,277 -0,449 -,646(*) -0,465 0,42 0,151 0,079 1,000 -0,532 -0,033 0,444 0 0,05 -0,057 0,264 0,354 0,295 -0,422 -0,368 -0,068
24 : 1 n-9 -0,249 -0,033 0,389 0,293 0,01 -0,121 -0,457 -0,483 1,000 0,419 -0,335 -0,153 -0,127 0,22 -0,513 0,068 -0,36 0,248 -0,083 -0,305
SM 0,12 0,025 0,432 ,628(*) -0,19 0,492 -0,413 -0,147 0,443 1,000 -0,486 -0,219 0,107 -0,104 -,679(*) -0,397 -0,495 0,278 -,622(*) -,665(*)
PC 0,212 -0,129 -0,274 -0,046 -0,218 ,627(*) 0,044 0,424 -,553(*) -0,058 1,000 0,522 0,415 0,528 0,234 0,309 0,154 -0,59 ,608(*) ,692(*)
PS -0,221 -0,447 -0,457 -0,173 0,093 0,416 -0,203 ,817(**) -0,292 0,045 ,645(*) 1,000 0,504 0,383 -0,11 -0,097 -0,422 -0,021 0,502 0,269
PI -0,039 -0,302 -0,445 -0,392 0,094 0,352 -0,082 ,782(**) -0,504 0,039 ,699(**) ,834(**) 1,000 0,039 -0,108 -0,494 -0,137 -0,165 0,293 0,175
PG -0,385 -0,452 -0,429 -0,203 -0,299 0,166 -0,452 0,142 -0,114 -0,019 0,449 0,432 0,512 1,000 -0,025 0,272 -0,101 -0,379 0,547 0,273
PE 0,153 0,084 0,055 -0,015 0,19 -0,259 ,619(*) 0,3 -0,316 -0,464 0,087 0,285 0,119 -0,109 1,000 0,494 ,890(**) -,627(*) 0,185 0,222
SULFATIDES 0,152 0,39 0,465 0,362 -0,124 -0,245 0,369 -,637(*) 0,427 -0,125 -,543(*) -,694(**) -,890(**) -,542(*) 0,163 1,000 0,545 -,621(*) 0,043 0,158
CEREBROSIDES 0,315 0,482 0,422 0,255 -0,019 -0,339 ,707(**) -0,433 0,051 -0,305 -0,418 -,602(*) -,705(**) -,596(*) 0,462 ,885(**) 1,000 -,715(*) 0,064 0,206
CHO -,655(*) -,554(*) -,631(*) -,641(*) 0,428 -,551(*) -0,513 0,151 -0,04 -0,413 -0,242 0,012 0,043 0,201 -0,253 -0,328 -0,399 1,000 -0,289 -0,37
FFA ,809(**) ,684(**) 0,509 0,51 -,678(**) ,710(**) 0,287 -0,328 -0,24 0,239 0,441 -0,166 -0,031 -0,07 -0,195 0,096 0,117 -,655(*) 1,000 ,849(**)














 Aging alters lipid contents of Lipid rafts from frontal cortex in normal 
subjects 
 Alterations involve plasmalogens, polyunsaturates, and total polar/neutral 
lipids  
 This “Lipid raft aging” exhibits gender differences 
 Interaction Aging and gender modify lipid alterations in lipid rafts  
 
 
